Fei Yu
- Infectious Diseases top 0.5%
- Epidemiology top 5%
- Molecular Biology
- Virology top 2%
- Radiology, Nuclear Medicine and Imaging top 5%
- Topics
- HIV Research and Treatment (34 papers)HIV/AIDS drug development and treatment (28 papers)Influenza Virus Research Studies (15 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Fei Yu
75 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 132
- Infectious Diseases 1.7k
- Epidemiology 862
- Molecular Biology 578
- Virology 402
- Radiology, Nuclear Medicine and Imaging 282
Countries citing papers authored by Fei Yu
This map shows the geographic impact of Fei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Yu more than expected).
Fields of papers citing papers by Fei Yu
This network shows the impact of papers produced by Fei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Yu. The network helps show where Fei Yu may publish in the future.
Co-authorship network of co-authors of Fei Yu
This figure shows the co-authorship network connecting the top 25 collaborators of Fei Yu. A scholar is included among the top collaborators of Fei Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Yu. Fei Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 13 | |
| 5 | 57 | |
| 6 | 8 | |
| 7 | 11 | |
| 8 | 77 | |
| 9 | 10 | |
| 10 | 270 | |
| 11 | 118 | |
| 12 | 23 | |
| 13 | 14 | |
| 14 | 14 | |
| 15 | 28 | |
| 16 | 24 | |
| 17 | 16 | |
| 18 | Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitorbreakdown → | 317 |
| 19 | 88 | |
| 20 | Characteristics of inferior variation of water environment in Hutuohe River dried-up area | 2 |
About Fei Yu
Fei Yu is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 83 papers that have together received 2.8k indexed citations. Recurring topics across this work include HIV Research and Treatment (34 papers), HIV/AIDS drug development and treatment (28 papers) and Influenza Virus Research Studies (15 papers). The work is most often cited by research in Infectious Diseases (1.7k citations), Virology (402 citations) and Animal Science and Zoology (264 citations). Fei Yu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Shibo Jiang, Lanying Du, Lu Lu, Ruiying Liang, Chungen Pan, David M. Ojcius, Xiaoqian Deng, Lili Wang, Meng Su and Naru Zhang. Their work appears in journals such as The Lancet, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.